Home / ADXN : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ADXN make money? Does ADXN have pricing power? What's the Earnings Whisper? Will ADXN profit more as the business scales? What is ADXN's management track record? Is ADXN's current price justified?

Addex Therapeutics Ltd

$3.49 -$4.60 (-56.86%)

NASDAQ · 11 Sep 2026 20:00 UTC

Previous Close

$3.39

Day Range

$3.36$3.55

Year Range

$3.3$11.97

Market Cap

4.3M

AVG Volume

95.4K

Trailing/Forward PE

-0.43/-

PEG ratio

0.02

Dividend Yield

Next Earnings Date

2026-11-09

Primary Exchange

NASDAQ

Revenue (CHF)

ADXN Revenue (CHF) by year
Period	Revenue (CHF)
2025	66.35K
2024	404.1K
2023	1.61M
2022	1.42M
2021	2.92M
2020	3.61M
2019	2.76M
2018	6.7M
2017	499.89K
2016	411.74K

Net Income (CHF)

ADXN Net Income (CHF) by year
Period	Net Income (CHF)
2025	-6.73M
2024	7.06M
2023	-10.56M
2022	-20.8M
2021	-15.35M
2020	-12.86M
2019	-14.78M
2018	-1.64M
2017	-3.28M
2016	-3.15M

Operating Income (CHF)

ADXN Operating Income (CHF) by year
Period	Operating Income (CHF)
2025	-2.81M
2024	-2.76M
2023	-4.2M
2022	-20.52M
2021	-15.51M
2020	-12.24M
2019	-14.6M
2018	-1.42M
2017	-3.24M
2016	-3.13M

EBITDA (CHF)

ADXN EBITDA (CHF) by year
Period	EBITDA (CHF)
2025	-6.83M
2024	-4.65M
2023	-4.14M
2022	-20.43M
2021	-14.94M
2020	-12.38M
2019	-14.32M
2018	-1.42M
2017	-3.22M
2016	-3.1M

Cash Flows (CHF)

ADXN Cash Flows (CHF) by year
Period	Cash Flows (CHF)
2025	-2.16M
2024	-5.37M
2023	-8M
2022	-16.44M
2021	-14.74M
2020	-12.24M
2019	-9.51M
2018	1.74M
2017	-2.14M
2016	-2.71M

EPS (CHF)

ADXN EPS (CHF) by year
Period	EPS (CHF)
2025	-7.41
2024	8.44
2023	-16.84
2022	-58.46
2021	-55.04
2020	-57.53
2019	-68.4
2018	-4.9
2017	-30.56
2016	-31.66

Expenses (CHF)

ADXN Expenses (CHF) by year
Period	Expenses (CHF)
2025	2.08M
2024	2.11M
2023	4.59M
2022	21.97M
2021	17.54M
2020	18.11M
2019	17.22M
2018	8.27M
2017	3.74M
2016	3.55M

Cash & Debt (CHF)

ADXN Cash & Debt (CHF) by year
Period	Cash & Debt (CHF)
2025	1.64M
2024	3.35M
2023	3.87M
2022	6.96M
2021	20.5M
2020	18.76M
2019	31.55M
2018	41.68M
2017	2.59M
2016	1.42M

Debt ratios

ADXN Debt ratios by year
Period	Debt ratios
2025	0.04
2024	0.07
2023	0.07
2022	0.11
2021	0.46
2020	0.58
2019	1.41
2018	4.03

Margins

ADXN Margins by year
Period	Margins
2025	-253.38%
2024	100%
2023	100%
2022	100%
2021	100%
2020	98.4%
2019	-9.24%
2018	28.61%
2017	-425.89%
2016	-497.8%

Return on Capital

ADXN Return on Capital by year
Period	Return on Capital
2025	-141.14%
2024	72.91%
2023	-921.57%
2022	-423.46%
2021	-90.67%
2020	-88.01%
2019	-57.91%
2018	-4.19%
2017	-244.35%
2016	-1440.76%

Shares Outstanding

ADXN Shares Outstanding by year
Period	Shares Outstanding
2025	1.19M
2024	815.2K
2023	793.64K
2022	497.46K
2021	289.81K
2020	223.05K
2019	219.44K
2018	221.86K
2017	108.82K
2016	97.85K

Book Value Per Share (CHF)

ADXN Book Value Per Share (CHF) by year
Period	Book Value Per Share (CHF)
2025	4.02
2024	11.87
2023	1.44
2022	9.88
2021	58.42
2020	65.5
2019	116.32
2018	176.87
2017	12.34
2016	2.23

Total Assets (CHF)

ADXN Total Assets (CHF) by year
Period	Total Assets (CHF)
2025	6.37M
2024	10.68M
2023	4.64M
2022	8.28M
2021	22.54M
2020	20.18M
2019	33.03M
2018	42.21M
2017	3.06M
2016	1.68M

Employee Count

ADXN Employee Count by year
Period	Employee Count
2025	3
2024	2
2023	23
2022	24
2021	28
2020	27
2019	18

PE Ratio

ADXN PE Ratio by year
Period	PE Ratio
Sep 25	0.67
Sep 25	0.68
Sep 25	0.8
Sep 25	0.61
Aug 25	0.6
Aug 25	0.66
Aug 25	0.6
Aug 25	0.62
Aug 25	0.62
Jul 25	0.64
Jul 25	0.57
Jul 25	0.66
Jul 25	0.7
Jun 25	0.68
Jun 25	0.65
Jun 25	0.78
Jun 25	0.97
May 25	0.76
May 25	0.8
May 25	0.82
May 25	1.01
May 25	1
Apr 25	1.01
Apr 25	0.92
Apr 25	0.89
Apr 25	0.96
Mar 25	1.07
Mar 25	1.01
Mar 25	1
Mar 25	1.02
Feb 25	1.15
Feb 25	1.01
Feb 25	0.99
Feb 25	1.06
Jan 25	1.05
Jan 25	1.15
Jan 25	1.1
Jan 25	1.04
Jan 25	1.14
Dec 24	1.02
Dec 24	1.06
Dec 24	1.07
Dec 24	1.08
Nov 24	1.15
Nov 24	1.01
Nov 24	1.35
Nov 24	1.74
Nov 24	1.75
Oct 24	1.8
Oct 24	1.7
Oct 24	1.65
Oct 24	1.52
Sep 24	1.43
Sep 24	1.57
Sep 24	1.54
Sep 24	1.77
Aug 24	1.74

Free Cash Flow Yield

ADXN Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-57.25%
Sep 26	-55.17%
Aug 26	-52.49%
Aug 26	-41.21%
Aug 26	-33.73%
Aug 26	-34.82%
Jul 26	-38.87%
Jul 26	-33.86%
Jul 26	-35.47%
Jul 26	-31.85%
Jul 26	-35.06%
Jun 26	-33.21%
Jun 26	-36.55%
Jun 26	-35.46%
Jun 26	-39.08%
May 26	-35.1%
May 26	-33.99%
May 26	-34.01%
May 26	-31.62%
May 26	-30.68%
Apr 26	-30.57%
Apr 26	-31.95%
Apr 26	-32.25%
Apr 26	-36.72%
Mar 26	-31.37%
Mar 26	-37.65%
Mar 26	-30.84%
Mar 26	-30.19%
Feb 26	-30%
Feb 26	-30.03%
Feb 26	-29%
Feb 26	-27.39%
Jan 26	-28.35%
Jan 26	-26.89%
Jan 26	-25.11%
Jan 26	-26.86%
Jan 26	-26.19%
Dec 25	-26.61%
Dec 25	-26.94%
Dec 25	-26.03%
Dec 25	-26.85%
Nov 25	-32.51%
Nov 25	-31.49%
Nov 25	-29.78%
Nov 25	-29.25%
Oct 25	-27.3%
Oct 25	-26.2%
Oct 25	-23.03%
Oct 25	-26.53%
Oct 25	-27.36%
Sep 25	-64.69%
Sep 25	-64.52%
Sep 25	-54.16%
Sep 25	-71.45%
Aug 25	-72.93%
Aug 25	-65.96%
Aug 25	-72.05%
Aug 25	-70.06%
Aug 25	-70.87%
Jul 25	-67.74%
Jul 25	-76.34%
Jul 25	-65.61%
Jul 25	-61.91%
Jun 25	-64.2%
Jun 25	-66.7%
Jun 25	-97.06%
Jun 25	-78.42%
May 25	-100%
May 25	-95.63%
May 25	-92.66%
May 25	-109.22%
May 25	-110.29%
Apr 25	-108.92%
Apr 25	-119.67%
Apr 25	-123.86%
Apr 25	-115.09%
Mar 25	-103.78%
Mar 25	-109.64%
Mar 25	-110.25%
Mar 25	-108.54%
Feb 25	-95.86%
Feb 25	-109%
Feb 25	-111.12%
Feb 25	-104.49%
Jan 25	-104.79%
Jan 25	-95.94%
Jan 25	-100.9%
Jan 25	-106.78%
Jan 25	-96.76%
Dec 24	-108.46%
Dec 24	-104.24%
Dec 24	-103.03%
Dec 24	-102.72%
Nov 24	-95.86%
Nov 24	-109.26%
Nov 24	-134.59%
Nov 24	-104.31%
Nov 24	-103.54%
Oct 24	-100.96%
Oct 24	-106.75%

Price to Sales

ADXN Price to Sales by year
Period	Price to Sales
Sep 26	54.9
Sep 26	56.98
Aug 26	59.89
Aug 26	76.27
Aug 26	93.19
Aug 26	90.27
Jul 26	80.86
Jul 26	92.83
Jul 26	88.62
Jul 26	98.69
Jul 26	89.66
Jun 26	94.65
Jun 26	89.09
Jun 26	91.83
Jun 26	83.32
May 26	92.76
May 26	95.79
May 26	95.73
May 26	73.68
May 26	75.95
Apr 26	76.23
Apr 26	72.93
Apr 26	72.26
Apr 26	63.46
Mar 26	74.27
Mar 26	61.89
Mar 26	75.57
Mar 26	77.18
Feb 26	77.67
Feb 26	77.6
Feb 26	80.34
Feb 26	85.07
Jan 26	82.19
Jan 26	86.67
Jan 26	92.8
Jan 26	86.74
Jan 26	88.97
Dec 25	87.55
Dec 25	86.48
Dec 25	89.5
Dec 25	86.78
Nov 25	48.36
Nov 25	49.92
Nov 25	52.8
Nov 25	53.75
Oct 25	57.58
Oct 25	60.01
Oct 25	68.27
Oct 25	59.27
Oct 25	57.47
Sep 25	34.24
Sep 25	34.33
Sep 25	40.9
Sep 25	31
Aug 25	30.37
Aug 25	33.58
Aug 25	30.74
Aug 25	31.61
Aug 25	31.25
Jul 25	32.7
Jul 25	29.02
Jul 25	33.76
Jul 25	35.78
Jun 25	34.5
Jun 25	33.21
Jun 25	13.7
Jun 25	16.96
May 25	13.3
May 25	13.9
May 25	14.35
May 25	9.84
May 25	9.74
Apr 25	9.86
Apr 25	8.98
Apr 25	8.67
Apr 25	9.34
Mar 25	10.35
Mar 25	9.8
Mar 25	9.74
Mar 25	9.9
Feb 25	11.21
Feb 25	9.86
Feb 25	9.67
Feb 25	10.28
Jan 25	10.25
Jan 25	11.2
Jan 25	10.65
Jan 25	10.06
Jan 25	11.1
Dec 24	9.91
Dec 24	10.31
Dec 24	10.43
Dec 24	10.46
Nov 24	11.21
Nov 24	9.83
Nov 24	7.01
Nov 24	9.04
Nov 24	9.11
Oct 24	9.34
Oct 24	8.83

Price to Book

ADXN Price to Book by year
Period	Price to Book
Sep 26	1.24
Sep 26	1.28
Aug 26	1.35
Aug 26	1.72
Aug 26	2.1
Aug 26	2.03
Jul 26	1.82
Jul 26	2.09
Jul 26	2
Jul 26	2.22
Jul 26	2.02
Jun 26	2.13
Jun 26	1.24
Jun 26	1.28
Jun 26	1.16
May 26	1.29
May 26	1.33
May 26	1.33
May 26	0.84
May 26	0.86
Apr 26	0.86
Apr 26	0.83
Apr 26	0.82
Apr 26	0.72
Mar 26	0.84
Mar 26	0.7
Mar 26	0.86
Mar 26	0.88
Feb 26	0.88
Feb 26	0.88
Feb 26	0.91
Feb 26	0.97
Jan 26	0.93
Jan 26	0.98
Jan 26	1.05
Jan 26	0.98
Jan 26	1.01
Dec 25	0.99
Dec 25	0.98
Dec 25	1.02
Dec 25	0.98
Nov 25	0.61
Nov 25	0.63
Nov 25	0.67
Nov 25	0.68
Oct 25	0.73
Oct 25	0.76
Oct 25	0.87
Oct 25	0.75
Oct 25	0.73
Sep 25	0.7
Sep 25	0.71
Sep 25	0.84
Sep 25	0.64
Aug 25	0.62
Aug 25	0.69
Aug 25	0.63
Aug 25	0.65
Aug 25	0.64
Jul 25	0.67
Jul 25	0.6
Jul 25	0.69
Jul 25	0.74
Jun 25	0.71
Jun 25	0.68
Jun 25	0.57
Jun 25	0.71
May 25	0.56
May 25	0.58
May 25	0.6
May 25	0.49
May 25	0.49
Apr 25	0.5
Apr 25	0.45
Apr 25	0.44
Apr 25	0.47
Mar 25	0.52
Mar 25	0.49
Mar 25	0.49
Mar 25	0.5
Feb 25	0.56
Feb 25	0.5
Feb 25	0.49
Feb 25	0.52
Jan 25	0.52
Jan 25	0.56
Jan 25	0.54
Jan 25	0.51
Jan 25	0.56
Dec 24	0.5
Dec 24	0.52
Dec 24	0.52
Dec 24	0.53
Nov 24	0.56
Nov 24	0.49
Nov 24	0.46
Nov 24	0.59
Nov 24	0.6
Oct 24	0.61
Oct 24	0.58

No video analysis for this stock yet. Request one from our team.

News: ADXN

globenewswire.com · 26 Aug 2026

ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, August 26, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it has raised gross proceeds of USD 2.8 million (CHF 2.2 million) through the sale of 437,869 ADSs representing 52,544,280 shares, through it's At the Market (ATM) offering agreement with H.C.

seekingalpha.com · 25 Jun 2026

Addex Therapeutics Ltd (ADXN) Q1 2026 Earnings Call Transcript

globenewswire.com · 25 Jun 2026

Addex Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, June 25, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today reported its Q1 2026 financial results and provided a corporate update.

globenewswire.com · 22 Jun 2026

Addex Therapeutics to Report 2026 First Quarter Financial Results and Host Conference Call on June 25, 2026

Geneva, Switzerland, June 22, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will report its First Quarter 2026 Financial Results on June 25, 2026. Tim Dyer, CEO and Mikhail Kalinichev, Head of Translational Science, will provide a business update and review of the Addex product pipeline during a teleconference and webcast for investors, analysts and media at 16:00 CEST (15:00 BST / 10:00 EDT / 07:00 PDT) on June 25, 2026.